Karyopharm Therapeutics Inc. · 10 hours ago
Senior Analytics Developer
Maximize your interview chances
Health CareMedical
Comp. & BenefitsNo H1B
Insider Connection @Karyopharm Therapeutics Inc.
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Deliver well-organized, insightful data outputs to internal stakeholders at KPTI.
Analyze and interpret clinical trial, genomic, and real-world evidence (RWE) data.
Design an integrated data architecture that connects multiple sources to enable data mining, machine learning, and AI applications.
Lead the creation and maintenance of automated data pipelines for seamless data processing.
Facilitate data imports and exports to support a unified data environment.
Develop and enhance the user interface (UI) for optimal data accessibility.
Manage and control user access to data analytics systems.
Identify and propose opportunities for analytical and process optimization.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
B.S., Masters, or PhD in Computer Science, Applied Mathematics, Computational Biology, Bioinformatics, Data-Science, or a related field.
5 - 8 Years Experience in medical and/or biological data analytics and related technologies.
Strong written verbal and written communication skills.
Drive to identify challenges and the solutions to address them.
Ability to work independently in a fast-paced environment.
Experience in developing secure web-based applications.
Comfortable working with large datasets and designing/building high performance data-intensive front-end solutions using a blend of tables and visualizations.
Proficiency in Python, R, SAS, or other compiled programming languages.
Demonstrated skill in the use of one or more analytic software tools or languages (e.g. Tableau, Power BI, Ruby, JavaScript, HTML, CSS).
Preferred
Preferred experience with mentoring and growing direct reports.
Preferred experience in elluminate.
Preferred experience with clinical trial data.
Company
Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc.
Funding
Current Stage
Public CompanyTotal Funding
$546.7MKey Investors
Avidity PartnersForesite CapitalDelphi Ventures
2022-12-05Post Ipo Equity· $165M
2020-03-02Post Ipo Equity· $172.5M
2014-06-30Post Ipo Equity· $111M
Recent News
Company data provided by crunchbase